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Periosteal osteosarcoma is a rare subtype of osteosarcoma. Wide surgical removal is the commonly used
treatment-method algorithm. However, the limb-salvage procedure of periosteal osteosarcoma in the distal
tibia is a technical challenge to orthopedic surgeons because of the scarcity of soft tissue and subcutaneous
nature in the anteromedial aspect. We encountered a 16-year-old female patient with periosteal osteosarcoma in
the distal half of the left tibia diagnosed preoperatively based upon the CT images and a needle biopsy. A unique
identical surgical technique was applied in the case, including marginal resection of the periosteal osteosarcoma
with part of the tibia retained at the same level of bone defect and reconstruction using the autologous fibula graft. A
combination of cisplatin and doxorubicin was received as chemotherapy after the operation. Postoperative incisional
biopsy was performed, and the hematoxylin-eosin-stained results confirmed the diagnosis of periosteal osteosarcoma.
The patient was followed up for 11 years. Radiological and clinical evaluation was performed at each follow-up. The
retained tibia incorporated well with the fibula autograft, and excellent limb functional recovery was achieved. The
patient was free from neoplastic disease at the latest follow-up. In conclusion, young patients with periosteal
osteosarcoma without intramedullary involvement can be treated by marginal resection of the lesion with part of
the tibia retained at the level of bone defect and reconstructed using a long autologous fibula graft. Subsequent
chemotherapy with administration of cisplatin and doxorubicin is recommended.
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Periosteal osteosarcoma is a relatively well-differentiated
chondroblastic osteosarcoma and is less aggressive than
conventional osteosarcoma [1]. It often occurs on the
surface of the long bones of the extremities [2]. The le-
sion locates most frequently on the diaphysis of the tibia
and femur [3]. Wide surgical resection is the mainstay of
treatment methods of periosteal osteosarcoma, which
often leads to large diaphyseal bone defect [4]. The re-
construction of a large bone defect of the tibia is a surgi-
cal challenge because of the scarcity of soft tissue and* Correspondence: dryzzhang@126.com
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There are no autologous bone grafts with proper size to
bridge the gap in some cases with a large bone defect. In
such a condition, we treat the lesions by marginal resec-
tion of the periosteal osteosarcoma with part of the tibia
retained at the same level of bone defect and reconstruc-
tion using the autologous fibula graft harvested from the
right lower extremity. The graft fibula and the retained
tibia serve as the structure supporter. Here, we present
such a case free from neoplastic disease recurrence at a
follow-up period of 11 years.Case presentation
A 16-year-old girl presented with a 6-month history of
intermittent pain and swelling over the anterior medial
aspect of the distal diaphysis of her left tibia. The paindistributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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bony mass grew into 3 × 6 cm in size when she was ad-
ministrated into our hospital. A palpable, immobile, and
mild tender mass was noted 5 months prior to adminis-
tration. The local skin appeared normal without redness
and venous engorgement. The radiographs of the distal
tibia shaft demonstrated a mass on the bone surface,
which contained radiolucent and sclerotic regions. The
radiographs also showed thickened underlying diaphy-
seal cortex and perpendicular periosteal reaction ex-
tending into the soft tissue mass (Fig. 1). Computed
tomography was taken, and the lesion was about one
half of the circumference of the tibia in width without
obvious medullary involvement (Fig. 2). According to
the radiological features, parosteal and periosteal osteo-
sarcoma were considered. A needle biopsy was carried
out. The hematoxylin-eosin-stained results revealed the
lobules of neoplastic cartilage with myxoid matrix, which
implied periosteal osteosarcoma.
Marginal resection of the periosteal osteosarcoma was
performed. At the time of surgery, the lesion margin was
firstly identified based upon the CT findings. The lesion
was approached by way of an anteromedial incision. Me-
ticulous dissection was performed to preserve sufficientFig. 1 The radiographs demonstrate thickened diaphyseal cortex
and perpendicular periosteal reaction extending into the soft tissue
in the anteromedial aspect of the tibia. a Anteroposterior view;
b lateral viewprotective margins of tissue. The tumor was exposed
and appeared as thickened and enlarged sclerotic bone
without adjacent soft tissue mass. Surgical margin of the
tumor was finally defined according to the CT images
and gross inspection. The bone was excised more than 2
cm away from the margins of the tumor. The lesion and
surrounding normal bone were removed. The bone
block, about three fifths of the circumference in width
and 12 cm in length of the affected tibia, was excised. A
large bone defect was left. The retained tibia was about
two fifths of the circumference in width at the level of
bone defect, which maintained the nature continuity
with that superior and inferior to the bone defect. Pre-
liminary evaluation of the surgical margin and intrame-
dullary cavity was performed immediately after removal
of the tumor. The bony resection margins were judged
clear, and the intramedullary aspect of the lesion was
assessed to be uninvolved by gross observation.
A fibular autograft was harvested from the right lower
leg to reconstruct the bone defect of the left tibia. A
straight incision about 18 cm in length was made from
the point 10 cm above the lateral malleolus along the
posterior border of the fibula. The fibula was reached via
the posterolateral approach. An 18-cm long fibular bone
block was resected. Both ends of the fibular graft were
trimmed, and the medullary canal of the tibia was
reamed. The fibular graft was firmly impacted into the
proximal and distal medullary canal of the left tibia. The
wound was closed in order, and a plaster cast was ap-
plied to stabilize the calf, the knee, and ankle joints.
Incisional biopsy tissues were gained postoperatively from
multiple sites of the resected tumor and along the surgical
margins for histopathological analysis. The hematoxylin-
eosin-stained results confirmed the preoperative diagnosis
of periosteal osteosarcoma (Fig. 3), grade 2 according to the
staging system of Enneking [5]. The histopathological
examination showed that the margin of the specimen was
clear from tumor cells, and no medullary involvement
was identified. Postoperative radiographs of the left
lower leg were taken, which demonstrate the retained
tibia and the bone defect reconstructed with fibular
autograft and stabilized using a plaster cast (Fig. 4).
The patient received chemotherapy, a combination of
cisplatin and doxorubicin, as would be used for conven-
tional osteosarcoma [6–8].
The postoperative course was uneventful. The patient
was encouraged to perform isometric muscle exercises of
the affected lower extremity and full range of motion of
the hip joint as soon as pain could be tolerated. Non-
weight-bearing crutch walking was allowed after soft
tissue healing. The cast was removed at 3 months pos-
toperatively, and partial weight bearing was permitted,
progressing to full weight bearing at 6 months. Follow-up
was conducted at 1, 3, 6, and 12 months after the
Fig. 2 Computed tomography reveals cortical thickening and extrinsic scalloping of the cortex without medullary involvement. a Axial image;
b sagittal image
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ical evaluation was performed at each follow-up. Excellent
bony healing of the tibia and fibula graft was observed on
the radiographs of the left lower limb at 6 months, and the
patient regained normal walking function without a crutch.
The retained tibia at the bone defect level grew and grad-
ually wrapped the fibula graft. The tibia incorporated wellFig. 3 Low-power view reveals typical periosteal osteosarcoma features,
which consisted of the lobules of neoplastic cartilage and myxoid
matrix, surrounded by fibrous membrane; the cartilage composed of
atypical chondroblastic cells (hematoxylin and eosin, ×40)with the fibula graft at 36 months postoperatively. The ra-
diographs at 60 months of follow-up demonstrated that
the fibula graft was almost absorbed. The reconstructed
tibia nearly regained the diameter as the contralateral un-
affected tibia (Fig. 5). At the latest follow-up, 11 years after
the operation, the radiographs and CT scan of the bilateral
lower extremities were taken, showing good remolding of
the retained tibia and fibular autograft (Figs. 6 and 7). The
muscle strength of the bilateral lower limbs were evaluated
both as normal (grade 5) according to the Manual Muscle
Testing Grading System. Single-legged hop tests [9, 10]Fig. 4 The radiographs demonstrate the retained tibia and fibula
graft in the bone defect. a Anteroposterior view; b lateral view
Fig. 5 a, b The radiographs show that the fibula graft is almost
absorbed, and the tibia is nearly as thick as the contralateral tibia
at 60-month follow-up
Fig. 7 Computed tomography taken at the latest follow-up reveals
good remolding of the retained tibia and fibular autograft. a Coronal
view, b sagittal view, and c 3-D reconstruction
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self-reported normal function of the bilateral knees. The
patient can now conduct daily activities and manual
work with a score of 100 according to the Activities of
Daily Living (ADL) questionnaire. During the follow-upFig. 6 At the 11-year follow-up, the radiographs of the bilateral lower extremities demonstrated good remolding of the retained tibia and
fibular autograft. a Anteroposterior view of right tibia, b lateral view of right tibia, c anteroposterior view of the left tibia, and d lateral view of
the left tibia
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distant metastasis occurred in the patient.
Discussion
In the current study, we treated a young female patient
with periosteal osteosarcoma by marginal resection
with retained tibia at the same level of bone defect and
reconstruction using the autologous fibula graft. Chemo-
therapy was received postoperatively. The retained tibia
incorporated with the graft fibula well, and excellent
limb function was achieved. Local recurrence or distal
metastasis was not reported at the 11-year follow-up.
Periosteal osteosarcoma was described in 1976 by Unni
and his colleagues [11]. Histologically, it consists of a large
chondroblastic tissue with smaller areas of osteoid for-
mation [3]. Radiographically, it appears as a well-defined,
essentially radiolucent mass probably with cortical thic-
kening, extrinsic scalloping of the cortex, and periosteal
reaction. CT and magnetic resonance (MR) imaging can
reveal the extent of the soft tissue mass. The large chon-
droid tissue is demonstrated as low attenuation at CT and
high signal intensity at T2-weighted MR imaging. There
is only occasional involvement of the underlying cortex.
The involvement of the medullary cavity is significant-
ly rare. Pathologically, periosteal osteosarcoma is an
intermediate-grade chondroblastic osteosarcoma (grade
2 or 3) [12–15].
Surgery is required to cue periosteal osteosarcoma, and
wide surgical excision is regarded as an appropriate therapy
[11, 13, 16]. However, a large bone defect is often a leftover
after wide resection. There are no autologous bone grafts
with proper size to bridge the gap in such cases. Massive al-
lografts are prone to infection [17]. Alternatively, marginal
section is also an option taking the low malignance of peri-
osteal osteosarcoma into consideration. Since local recur-
rence has a tendency to occur in case of incomplete
resection, the bony resection margins and the intramedul-
lary aspect of the lesion should be confirmed as clear at the
time of surgery.
Periosteal osteosarcoma occurs most often in adoles-
cents and has a predilection for the diaphysis of the tibia
or the femur [16]. The young patients have high demand
of the limb function. Limb-salvage surgery should be
performed in these patients. The limb-salvage procedure
of a malignant tumor in the distal tibia is a great chal-
lenge to orthopedic surgeons. The distal half of the di-
aphysis of the tibia has a few direct muscle attachments,
and only part of posterior tibialis posterior, flexor digi-
torum longus, and extensor digitorum longus are origi-
nated from the distal half of the tibia. The limb salvage
presents unique difficulties [18].
To reduce the difficulty encountered in the limb-salvage
surgery and preserve the limb function to the utmost ex-
tent, we treat the periosteal osteosarcoma by marginalresection. The lesion and its surrounding normal bone
was excised in the affected segment of the tibia. Part of
the tibia at the same level of bone defect was retained to
maintain the continuity of the cortex. The retained tibia
served as the structure supporter of the lower limb and
preserved the limb length. The bone defect was re-
constructed with a long autograft fibula, which was
trimmed and inserted into the intramedullary cavity.
The fibula graft had the following two main functions:
improving the osteogenesis and providing structure
support. No implant was needed. Accordingly, implant-
related complications or implant removal was avoided.
The tibia incorporated well with the autograft fibula at
36 months after surgery as demonstrated on CT. The
fibula graft was almost absorbed, and the reconstructed
tibia was nearly as thick as the contralateral unaffected
tibia. The muscle strength of the left lower extremities
was evaluated according to the Manual Muscle Testing
Grading System, and functional recovery of the left
knee joint assessed using single-legged hop tests were
both normal. The patient can now conduct daily activ-
ities and manual work without any difficulty. Compared
with limb-salvage surgery using prosthesis, the novel
technique is easy to perform. It is also economy-
friendly, especially in the developing country.
At the latest follow-up, no local recurrence or distal
metastasis was reported. Two factors may contribute to
these issues. At the time of surgery, the bony resection
margins and the intramedullary aspect of the lesion were
judged clear. Postoperative histopathological examination
confirmed the intraoperative judgment. In addition, the
cisplatin and doxorubicin were applied in the case. Con-
troversy remains as to whether chemotherapy is necessary
in the management of periosteal osteosarcoma [1, 11, 19,
20]. Previous studies have produced mixed results in this
consideration. In the report of Bertoni et al., a marginal
excision was done in eight patients with periosteal osteo-
sarcoma, and all but one was affected by a local recur-
rence [13]. Chemotherapy was not used in the initial
treatment in their study. Grimer and his colleagues also
reported that the use of chemotherapy was not shown to
be a prognostic factor, but the chemotherapy was used in
two thirds of the patients (80 patients) in their study, and
doxorubicin and cisplatin were used in 75 patients (93.8 %)
[21]. Revell and his colleagues claimed 100 % survival in
patients who have undergone adequate chemotherapy and
surgery [22]. While in our study, pre- and postoperative
chemotherapy were used, and no recurrence was found
during the follow-up period of 11 years.
Although the presented case demonstrated excellent
functional recovery without local recurrence or distal
metastasis for a long term of follow-up, this procedure
should be restricted to low-grade periosteal osteosar-
coma without medullary involvement. Larger numbers
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of this kind of reconstruction fairly.
Conclusions
This unique surgical technique, including marginal resec-
tion of periosteal osteosarcoma with part of the tibia
retained at the same level of bone defect and reconstruc-
tion using autologous fibula graft, and postoperative
chemotherapy, can be applied effectively in the treatment
of young patients. The patient has been continuously
disease-free during the follow-up period of 11 years after
surgery. The muscle strength of the bilateral lower limbs
were evaluated according to the Manual Muscle Testing
Grading System, and the bilateral knee functions assessed
using single-legged hop tests were both normal. This
treatment algorithm at our institution shed light on the
management of similar cases.
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